Ligand Pharmaceuticals OverviewLigand Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for LGND.
Quarterly Other Income/Expense
-$41.63M
↓ 198.1% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$90.30M
↑ 171.78% YoY
Trailing 12 months ending Mar 31, 2026